ETF1 anticorps (N-Term)
Aperçu rapide pour ETF1 anticorps (N-Term) (ABIN632229)
Antigène
Voir toutes ETF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- ETF1 antibody was raised against the N terminal of ETF1
-
Purification
- Affinity purified
-
Immunogène
- ETF1 antibody was raised using the N terminal of ETF1 corresponding to a region with amino acids ISLIIPPKDQISRVAKMLADEFGTASNIKSRVNRLSVLGAITSVQQRLKL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ETF1 Blocking Peptide, (ABIN939543), is also available for use as a blocking control in assays to test for specificity of this ETF1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ETF1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ETF1 (Eukaryotic Translation Termination Factor 1 (ETF1))
-
Autre désignation
- ETF1
-
Sujet
- Termination of protein biosynthesis and release of the nascent polypeptide chain are signaled by the presence of an in-frame stop codon at the aminoacyl site of the ribosome. The process of translation termination is universal and is mediated by protein release factors (RFs) and GTP.
-
Poids moléculaire
- 49 kDa (MW of target protein)
Antigène
-